Higher antidepressant dose may pose risks for seniors with weak kidneys
NCT ID NCT07399795
First seen Feb 16, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study looked at over 7,000 older adults (65+) with reduced kidney function to see if starting a higher dose (20 mg/day) of the antidepressant citalopram is riskier than a lower dose (10 mg/day). Researchers checked for hospital visits, emergency department visits, or death within 30 days. The goal was to gather safety information, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE(CKD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London Health Sciences Centre Research Institute
London, Ontario, Canada
Conditions
Explore the condition pages connected to this study.